159 related articles for article (PubMed ID: 19715634)
1. Value based pricing for NHS medicines: magic bullet, counterfeit treatment or the mixture as before?
Taylor D; Craig T
Health Econ Policy Law; 2009 Oct; 4(Pt 4):515-26. PubMed ID: 19715634
[No Abstract] [Full Text] [Related]
2. Margaret McCartney: We can save billions without cutting care.
McCartney M
BMJ; 2017 Feb; 356():j890. PubMed ID: 28223266
[No Abstract] [Full Text] [Related]
3. The link between publicly funded health care and compulsory licensing.
Hollis A
CMAJ; 2002 Oct; 167(7):765-6. PubMed ID: 12389839
[No Abstract] [Full Text] [Related]
4. International experience of paying for expensive medicines.
Desai M; Nolte E; Mays N; Nikolentzos A
BMJ; 2009 May; 338():b1993. PubMed ID: 19482871
[No Abstract] [Full Text] [Related]
5. Government review aims to speed up NHS access to new medicines.
Hawkes N
BMJ; 2014 Nov; 349():g7090. PubMed ID: 25422172
[No Abstract] [Full Text] [Related]
6. Data briefing. The NICE threshold.
Appleby J
Health Serv J; 2007 Sep; 117(6074):21. PubMed ID: 17970386
[No Abstract] [Full Text] [Related]
7. The impact of the NHS (Charges to Overseas Visitors) regulations (1989).
McLeod AC
Br J Nurs; 2009 Oct 22-Nov 11; 18(19):1188-91. PubMed ID: 19966745
[TBL] [Abstract][Full Text] [Related]
8. Fifth anniversary changes for NHS reforms.
Warden J
BMJ; 1996 Mar; 312(7031):600. PubMed ID: 8595331
[No Abstract] [Full Text] [Related]
9. Ways around the NHS.
Gollogly L
Lancet; 2004 Mar; 363(9413):914. PubMed ID: 15043957
[No Abstract] [Full Text] [Related]
10. Has this Labour government been good for the NHS?
Milburn A; Fox L
Nurs Times; 2000 Oct 5-11; 96(40):14. PubMed ID: 11968633
[No Abstract] [Full Text] [Related]
11. The end is CHI.
Donnelly L
Health Serv J; 2004 Mar; 114(5898):10, 12-3. PubMed ID: 15065301
[No Abstract] [Full Text] [Related]
12. Care quality commission. Failure to limit expectations is blighting NHS regulation.
McLellan A
Health Serv J; 2012 Mar; 122(6296):3. PubMed ID: 22571054
[No Abstract] [Full Text] [Related]
13. Value based pricing for NHS drugs: an opportunity not to be missed?
Claxton K; Briggs A; Buxton MJ; Culyer AJ; McCabe C; Walker S; Sculpher MJ
BMJ; 2008 Feb; 336(7638):251-4. PubMed ID: 18244997
[TBL] [Abstract][Full Text] [Related]
14. Risk, responsibility and regulation: whose risk is it?
Tingle J
Br J Nurs; 2007 Feb 8-21; 16(3):138. PubMed ID: 17363877
[No Abstract] [Full Text] [Related]
15. Regulation. A pause for thought.
Moore A
Health Serv J; 2011 Oct; 121(6278):23-4. PubMed ID: 22175115
[No Abstract] [Full Text] [Related]
16. 'Anxiety and disbelief' as DoH fiascoo scuppers business plans.
Mooney H
Health Serv J; 2006 Mar; 116(5995):5. PubMed ID: 16583864
[No Abstract] [Full Text] [Related]
17. The Office of Fair Trading report: a prescription for value-based drug pricing.
Minhas R; Moon JC
J R Soc Med; 2007 May; 100(5):216-8. PubMed ID: 17470928
[No Abstract] [Full Text] [Related]
18. New agreement on branded drugs for the NHS.
Naci H; Dixon J
BMJ; 2019 Jan; 364():l266. PubMed ID: 30658964
[No Abstract] [Full Text] [Related]
19. GPs, rather than the government, should be blamed for failures in new NHS, MPs are told.
O'Dowd A
BMJ; 2011 Oct; 343():d6820. PubMed ID: 22016455
[No Abstract] [Full Text] [Related]
20. NHS watchdog is failing patients and unfit for purpose, MPs are told.
O'Dowd A
BMJ; 2012 Jan; 344():e695. PubMed ID: 22286509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
